Syrs earnings report
WebMar 15, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.61 per share a year ago. WebAug 9, 2016 · SYRS - Syros Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings SYRS - Stock Price Chart SYRS [NASD]
Syrs earnings report
Did you know?
WebAug 6, 2024 · Syros Pharmaceuticals, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $3.19 million for the quarter ended June 2024, surpassing the Zacks Consensus... WebApr 10, 2024 · Syros Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros …
WebBased on 5 Wall Street analysts offering 12 month price targets for Syros Pharmaceuticals in the last 3 months. The average price target is $24.00 with a high forecast of $60.00 and a low forecast of $13.00. The average price target represents a 858.08% change from the last price of $2.51. Highest Price Target $60.00. Average Price Target $24.00. WebNov 14, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $2.41 per share versus the Zacks Consensus Estimate of a loss of $3.91. This compares to loss …
WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the... SYRS : 2.51 (-2.15%) VRDN : 25.41 (+1.97%) WebNov 14, 2024 · Syros Pharmaceuticals, Inc. (SYRS) came out with a quarterly loss of $2.41 per share versus the Zacks Consensus Estimate of a loss of $3.91. This compares to loss of $4.10 per share a year ago....
WebEarnings Summary For their last quarter, Syros Pharmaceuticals (SYRS) reported earnings of -$1.28 per share, missing the Zacks Consensus Estimate of -$1.27 per share. This …
WebSYRS Stock Price - Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and … homeready movement mortgageWebJan 30, 2024 · NASDAQ: SYRS Syros Pharmaceuticals Stock Earnings Report Current P/E ratio: -0.326 Price (Jan 30, 2024, EOD): $4.85 (Find current average P/E ratios for all … home ready non borrower incomeWebApr 14, 2024 · The Syros Pharmaceuticals stock price fell by -2.15% on the last day (Thursday, 6th Apr 2024) from $2.56 to $2.51. During the last trading day the stock fluctuated 6.61% from a day low at $2.42 to a day high of $2.58. The price has fallen in 7 of the last 10 days and is down by -10.85% for this period. home ready online courseWebSyros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. hinton deep learningWebApr 12, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) posted its quarterly earnings data on Thursday, March, 2nd. The company reported ($1.28) EPS for the quarter, missing … homeready need to be first time homebuyerWebRepresents the company's profit divided by the outstanding shares of its common stock. -0.17. 95.53%. EBITDA. Earnings before interest, taxes, depreciation, and amortization, is a measure of a ... hinton dental stansbury parkWebMar 2, 2024 · Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. hinton deep learning video by his student